Aegea Biotechnologies is a pioneering life science company committed to advancing precision medicine through innovative nucleic acid technologies. Our flagship Switch-Blocker™ platform enables ultra-sensitive and specific detection of rare genetic mutations, transforming diagnostics in oncology, infectious diseases, transplantation, and personalized medicine.

With a robust portfolio of 11 issued U.S. patents and validated clinical applications impacting over 30,000 patient samples, Aegea stands at the forefront of molecular diagnostics innovation. Our technologies seamlessly integrate with existing PCR and Next-Generation Sequencing (NGS) workflows, enhancing assay performance without the need for new instrumentation.

Our leadership team combines deep scientific expertise with strategic business acumen, having collectively contributed to the creation of over $7 billion in value across the biotechnology sector. This unique blend of innovation and execution positions Aegea as a trusted partner in the evolving landscape of life science tools and molecular diagnostics. Aegea is located in San Diego, CA.

AEGEA Biotechnologies

Org chart

Teams

Offices

AEGEA Biotechnologies

Org chart

Teams

Offices

Related companies